|
|
|
|
Direct Cost |
Indirect Cost |
|
| 1K99AG086524-01A1 |
Investigating TFEB as a critical node to improve proteostatic maintenance and skeletal muscle function with age |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIA |
$125,053 |
$10,004 |
$135,057 |
| 1K99AR086336-01 |
Articular Microbiome for Prediction and Potential Therapy of Periprosthetic Joint Infections |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIAMS |
$96,974 |
$7,758 |
$104,732 |
| 1P20GM156711-01 |
Center for Genomic Regulation |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIGMS |
$1,444,596 |
$1,018,440 |
$2,463,036 |
| 1R01AI183676-01A1 |
Defining the Regulatory Landscape of Lupus with CVD Comorbidity |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIAID |
$465,157 |
$327,936 |
$793,093 |
| 1R01AI190169-01 |
Resolving the mechanisms of IFIH1 risk variant in systemic lupus erythematosus |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIAID |
$1,836,176 |
$1,294,503 |
$3,130,679 |
| 1R01AI191517-01A1 |
Functional and Mechanistic Characterization of Lupus Susceptibility |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIAID |
$2,000,250 |
$1,364,685 |
$3,364,935 |
| 1R01DA060226-01A1 |
Effects of tobacco smoking on prognosis and immune function in multiple sclerosis |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIDA |
$323,840 |
$228,307 |
$552,147 |
| 1R01GM157525-01 |
Function and Regulation of DNA Replication Origin Firing Factors |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIGMS |
$462,000 |
$325,710 |
$787,710 |
| 1R01HL175157-01A1 |
Understanding Sarcoidosis Susceptibility and Disease Burden Through Multi Omics |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NHLBI |
$470,724 |
$307,542 |
$778,266 |
| 1R01NS135830-01A1 |
Influence of neuromelanin on single dopaminergic neurons in Parkinson's disease. |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NINDS |
$380,669 |
$235,531 |
$616,200 |
| 1R21AI194204-01 |
Notch regulation of airway epithelial-immune cell cross-talk in SARS-CoV-2 infection |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIAID |
$334,125 |
$114,563 |
$448,688 |
| 1R21DE034962-01A1 |
Aging, Sex Bias, and CD8 T Cell Exhaustion in Salivary Gland Inflammation |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIDCR |
$275,000 |
$193,875 |
$468,875 |
| 1R35GM154839-01 |
Novel pathways in heterochromatin regulation |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIGMS |
$250,000 |
$176,250 |
$426,250 |
| 1R35GM160259-01 |
Regulation of gene transcription and DNA replication by chromatin readers from the BET family |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIGMS |
$275,000 |
$193,875 |
$468,875 |
| 1RF1AG090599-01A1 |
A role for mitochondrial AMPK signaling in neurons |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIA |
$1,526,650 |
$1,076,290 |
$2,602,940 |
| 2R01AR076440-07 |
Peripheral blood mononuclear cell epigenetic associations in and biomarkers for knee osteoarthritis development and progression |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIAMS |
$1,257,246 |
$472,671 |
$1,729,917 |
| 3UC2AR081032-04S1 |
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIAMS |
$993,565 |
$686,362 |
$1 |
| 3UM1AI144292-07S1 |
Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIAID |
$265,175 |
$135,404 |
$400,579 |
| 4DP5OD033443-04 |
Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
OD |
$500,000 |
$374,000 |
$874,000 |
| 5F32AG087622-02 |
Determining the influence of metformin treatment on mitochondrial calcium flux during aerobic exercise training of healthy, aging rats |
OKLAHOMA MEDICAL RESEARCH FOUNDATION |
NIA |
$50,690 |
|
$50,690 |